Noriaki Kurose

Pictet AM Japan is an active, long-term manager which follows a value-oriented investment style to invest across market-caps and sectors. The firm primarily invests in domestic equity complemented by derivatives, and marginally in UK equity. They are focused on absolute returns and aim for market neutrality. Asset allocation results from a top-down approach based on economic fundamentals in a range of industry sectors. The investment process consists of bottom-up stock picking based on fundamental research which includes company visits.

Amova Asset Management is an active, growth-oriented manager offers both active and passive investment capabilities across equity, fixed income and alternative asset classes, with key strengths in multiple pan-Asian asset strategies. The firm’s general approach focuses on fundamental bottom-up analysis based on in-house research; although it will vary depending on specific requirements of the investment strategy pursued and is tailored accordingly. Through their overseas offices they invest globally, favoring Asian equity and US mid- and large-cap companies, as well as emerging markets. Their alternative investments follow strategies such as global fixed-income and currency arbitrage, Japanese market neutral, convertible bond and option-based arbitrage strategies, and multi-manager funds. They provide a broad coverage of global fixed income markets and currencies, with consideration to the following factors: macro fundamentals, interest rates, market liquidity, and investor positioning/relative performance.

SIM-JP is a long-term manager which follows a research-based, bottom-up investment process to invest in Japanese equity and debt across market-caps. They aim for diversification through asset allocation based on in-depth local economic analysis. The firm offers various investment strategies such as liquid alternative, alpha stock, credit, emerging market investment, income, and multi-asset operation solution.

Reaction invests in companies located across the globe. The firm targets companies operating in the fields of world health, environmental sustainability and Innovation Equity. It provides financing for early stage capital requirements.